1. Home
  2. ITOC vs TNON Comparison

ITOC vs TNON Comparison

Compare ITOC & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ITOC

iTonic Holdings Ltd Class A Ordinary Shares

N/A

Current Price

$0.28

Market Cap

7.0M

Sector

N/A

ML Signal

N/A

Logo Tenon Medical Inc.

TNON

Tenon Medical Inc.

HOLD

Current Price

$0.82

Market Cap

7.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITOC
TNON
Founded
1998
2012
Country
China
United States
Employees
N/A
27
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0M
7.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ITOC
TNON
Price
$0.28
$0.82
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
3.0M
152.5K
Earning Date
03-20-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$65.95
Revenue Next Year
N/A
$50.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$0.64
52 Week High
$0.65
$2.48

Technical Indicators

Market Signals
Indicator
ITOC
TNON
Relative Strength Index (RSI) 37.28 56.68
Support Level N/A $0.66
Resistance Level $0.38 $0.89
Average True Range (ATR) 0.05 0.05
MACD -0.00 0.01
Stochastic Oscillator 4.53 75.38

Price Performance

Historical Comparison
ITOC
TNON

About ITOC iTonic Holdings Ltd Class A Ordinary Shares

iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors.

About TNON Tenon Medical Inc.

Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

Share on Social Networks: